Buy Us a Cup of Coffee

Verrica Pharmaceuticals Inc. Announces Pricing of Initial Public Offering

West Chester-based Verrica Pharmaceuticals Inc. Announces Pricing of Initial Public Offering

WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA), a pharmaceutical company focused on identifying, developing and commercializing innovative pharmaceutical products for the treatment of skin diseases with significant unmet needs, recently announced the pricing of its initial public offering of 5,000,000 shares of its common stock at a public offering price of $15.00 per share, for total gross proceeds of approximately $75.0 million before underwriting discounts and commissions and estimated offering expenses.

In addition, Verrica has granted the underwriters a 30-day option to purchase up to an additional 750,000 shares of common stock at the public offering price, less underwriting discounts and commissions. All of the common stock is being offered by Verrica. The shares were scheduled to begin trading on the Nasdaq Global Market on June 15, 2018 under the ticker symbol “VRCA.” The offering is expected to close on June 19, 2018, subject to customary closing conditions.

READ:  Trump Administration’s Operation Warp Speed Accelerates AstraZeneca COVID-19 Vaccine to be Available Beginning in October

BofA Merrill Lynch, Jefferies and Cowen are serving as joint book-running managers for the offering.

A registration statement relating to the securities being sold in this offering was declared effective by the Securities and Exchange Commission on June 14, 2018. This offering is being made only by means of a prospectus. A copy of the final prospectus can be obtained, when available, from: BofA Merrill Lynch, NC1-004-03-43, 200 North College Street, 3rd Floor, Charlotte, NC 28255-0001, Attention: Prospectus Department, or by email at [email protected]; Jefferies, Attention: Equity Syndicate Prospectus Department, 520 Madison Avenue, 2nd Floor, New York, NY 10022, by phone at 1-877-821-7388 or by email at [email protected]; or Cowen, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, Attention: Prospectus Department, or by telephone at (631) 274-2806.

READ:  AmerisourceBergen Closes $500 Million Senior Note Offering

Verrica Pharmaceuticals Inc., 10 North High Street, Suite 200, West Chester PA 19380

Thanks for visiting! MyChesCo brings reliable information and resources to Chester County, Pennsylvania. Please consider supporting us in our efforts. Your generous donation will help us continue this work and keep it free of charge. Show your support today by clicking here and becoming a patron.

Buy Us a Cup of Coffee